Detalhe da pesquisa
1.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917453
2.
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Am J Hematol
; 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38884175
3.
A uniform conditioning regimen of busulfan, fludarabine, and antithymocyte globulin for allogeneic haematopoietic cell transplantation from haploidentical family, matched sibling, or unrelated donors-A single-centre, prospective, explorative study.
Br J Haematol
; 200(5): 608-621, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36370064
4.
Natural Killer Cell Activity Test Helps to Suspect Aggressive Natural Killer Cell Leukemia - Diagnostic Challenge.
Int J Med Sci
; 20(2): 206-210, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794163
5.
Real-World Treatment Patterns and Clinical Outcomes in Korean Patients With AML Ineligible for First-Line Intensive Chemotherapy: A Subanalysis of the CURRENT Study, a Non-Interventional, Retrospective Chart Review.
J Korean Med Sci
; 38(44): e345, 2023 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967874
6.
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea.
J Korean Med Sci
; 38(41): e328, 2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37873628
7.
Five-day versus 7-day treatment regimen with azacitidine in lower risk myelodysplastic syndrome: A phase 2, multicenter, randomized trial.
Cancer
; 128(23): 4095-4108, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208097
8.
Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome.
Br J Haematol
; 198(4): 703-712, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612271
9.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665578
10.
Unique ethnic features of DDX41 mutations in patients with idiopathic cytopenia of undetermined significance, myelodysplastic syndrome, or acute myeloid leukemia.
Haematologica
; 107(2): 510-518, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626862
11.
Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first-line systemic treatment or best supportive care: A multicenter international study.
Eur J Haematol
; 109(1): 58-68, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298049
12.
Busulfan, etoposide, cytarabine, and melphalan as a high-dose regimen for autologous stem cell transplantation in peripheral T-cell lymphomas.
Ann Hematol
; 100(1): 189-196, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205337
13.
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.
Haemophilia
; 27(5): e609-e616, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34156738
14.
Second allogeneic hematopoietic stem cell transplantation in patients with acute leukemia relapsed after allogeneic hematopoietic stem cell transplantation.
Clin Transplant
; 35(3): e14199, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33349948
15.
Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.
Mycoses
; 64(9): 1124-1131, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740824
16.
A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
J Korean Med Sci
; 36(43): e306, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751013
17.
Incidence, Management, and Prognosis of Graft Failure and Autologous Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
J Korean Med Sci
; 36(23): e151, 2021 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128593
18.
Treatment of Latent Tuberculosis Infection Based on the Interferon-γ Release Assay in Allogeneic Stem Cell Transplant Recipients.
Clin Infect Dis
; 71(8): 1977-1979, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31930297
19.
Differences in PD-1 expression on CD8+ T-cells in chronic myeloid leukemia patients according to disease phase and TKI medication.
Cancer Immunol Immunother
; 69(11): 2223-2232, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32474769
20.
Immunodeficiency risk score for prediction of mortality by parainfluenza virus infection in patients with hematologic malignancy.
Ann Hematol
; 99(6): 1231-1239, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382770